MENU
IPSC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Century Therapeutics (IPSC) Ownership - Who owns Century Therapeutics?
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases... Show more
Profile
Industry
N/A
Address
25 N 38th Street
Phone
+1 267 817-5790
Employees
165
Web
https://www.centurytx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
51.97M
P/E Ratio
N/A
Total Cash
198.11M
Projected Growth
N/A
Total Debt
54.6M
Revenue
2.68M
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash/Share
2.33
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
IPSC
Capitalization
52M
P/E Ratio
N/A
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash
198M
Total Cash/Share
2.33
Total Debt
54.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
2.68M
ROE
N/A
Book Value
196M
P/B Ratio
0.27
Cash Flow
N/A
Earnings
-1.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
10.39
Current Revenue Per Employee
4793.94
Dividends Per Share - Security
N/A
EBITDA
-117.21M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.04
Shares Held By Institutions
77.8M
Shares Outstanding - Current
85M
Total Liabilities
193M
Total Volume MTD
N/A
Value
-1
Gain YTD
-35.109
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
25 N 38th Street
Phone
+1 267 817-5790
Employees
165
Web
https://www.centurytx.com